Application | Comment | Organism |
---|---|---|
medicine | an hyperactive variant with enhanced solubility and stability can be delivered with transposon DNA to genetically modify cell lines and embryonic, hematopoietic and induced pluripotent stem cells. The variant is used to generate chimeric antigen receptor T-cells, which exhibit potent anti-tumor activity in vitro and in xenograft mice. The variant spontaneously penetrates cells, enabling modification of induced pluripotent stem cells and generation of generate chimeric antigen receptor T-cells without the use of transfection reagents | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | introduction of mutation I212S to variant SB100X increases solubility. Additional substitution C176S generates a remarkably high solubility. Mutations C197S, C304S and C316S compromise protein solubility | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
SB100X | - |
Homo sapiens |
sleeping beauty transposase | - |
Homo sapiens |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
95 | - |
stable up to, variant SB100X carrying mutations I212S/C176S | Homo sapiens |